NM_001382567.1:c.458C>T

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting

The NM_001382567.1(STIM1):​c.458C>T​(p.Thr153Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000299 in 1,598,430 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 0 hom. )

Consequence

STIM1
NM_001382567.1 missense

Scores

7
12

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:6

Conservation

PhyloP100: 3.12
Variant links:
Genes affected
STIM1 (HGNC:11386): (stromal interaction molecule 1) This gene encodes a type 1 transmembrane protein that mediates Ca2+ influx after depletion of intracellular Ca2+ stores by gating of store-operated Ca2+ influx channels (SOCs). It is one of several genes located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocrotical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region, as well as early hematopoiesis, by mediating attachment to stromal cells. Mutations in this gene are associated with fatal classic Kaposi sarcoma, immunodeficiency due to defects in store-operated calcium entry (SOCE) in fibroblasts, ectodermal dysplasia and tubular aggregate myopathy. This gene is oriented in a head-to-tail configuration with the ribonucleotide reductase 1 gene (RRM1), with the 3' end of this gene situated 1.6 kb from the 5' end of the RRM1 gene. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.15253848).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000217 (33/152272) while in subpopulation NFE AF= 0.000412 (28/68030). AF 95% confidence interval is 0.000292. There are 0 homozygotes in gnomad4. There are 19 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STIM1NM_001382567.1 linkc.458C>T p.Thr153Ile missense_variant Exon 4 of 13 ENST00000526596.2 NP_001369496.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STIM1ENST00000526596.2 linkc.458C>T p.Thr153Ile missense_variant Exon 4 of 13 5 NM_001382567.1 ENSP00000433266.2 H0YDB2

Frequencies

GnomAD3 genomes
AF:
0.000217
AC:
33
AN:
152154
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000412
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000199
AC:
45
AN:
226352
Hom.:
0
AF XY:
0.000239
AC XY:
29
AN XY:
121528
show subpopulations
Gnomad AFR exome
AF:
0.0000711
Gnomad AMR exome
AF:
0.000156
Gnomad ASJ exome
AF:
0.000418
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000369
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000325
Gnomad OTH exome
AF:
0.000178
GnomAD4 exome
AF:
0.000308
AC:
445
AN:
1446158
Hom.:
0
Cov.:
30
AF XY:
0.000300
AC XY:
215
AN XY:
717542
show subpopulations
Gnomad4 AFR exome
AF:
0.0000300
Gnomad4 AMR exome
AF:
0.000210
Gnomad4 ASJ exome
AF:
0.000349
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000241
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000376
Gnomad4 OTH exome
AF:
0.000134
GnomAD4 genome
AF:
0.000217
AC:
33
AN:
152272
Hom.:
0
Cov.:
32
AF XY:
0.000255
AC XY:
19
AN XY:
74444
show subpopulations
Gnomad4 AFR
AF:
0.0000481
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.000577
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000412
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000362
Hom.:
0
Bravo
AF:
0.000238
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000582
AC:
5
ExAC
AF:
0.000198
AC:
24

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:3
Jun 23, 2022
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Reported in both affected and unaffected individuals in a case-control study of patients with pancreatitis (Masson et al., 2019).; This variant is associated with the following publications: (PMID: Masson2019[casereport], 33468626) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Mar 17, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Combined immunodeficiency due to STIM1 deficiency Uncertain:1
Jun 05, 2020
New York Genome Center
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Myopathy, tubular aggregate, 1 Uncertain:1
Apr 21, 2023
New York Genome Center
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.458C>T variant in STIM1 has not previously been reported in the literature in individuals affected with STIM1-related conditions but it has been deposited in ClinVar as Variant of Uncertain Significance by multiple submitters [ClinVar ID: 461734]. The c.458C>T variant is observed in 171 alleles (~0.022% minor allele frequency with 0 homozygotes) in population databases (gnomAD v2.1.1 and v3.1.2, TOPMed Freeze 8), suggesting it is not a common benign variant in the populations represented in those databases, however, it is uncertain whether this frequency is higher than the disease prevalence or there might be individuals with subtle and slowly progressing symptoms among the variant carriers in those databases. The c.458C>T variant in STIM1 is located in exon 4 of this 12-exon gene and predicted to replace a moderately conserved threonine amino acid with isoleucine at position 153 in the SAM domain of the encoded protein. In silico predictions are not in favor of damaging effect for the p.(Thr153Ile) variant [(CADD v1.6 = 23, REVEL =0.328)]. In vitro studies conducted with this variant are inconclusive [PMID:33468626]. Based on available evidence this c.458C>T p.(Thr153Ile) variant identified in STIM1 is classified as a Variant of Uncertain Significance. -

Myopathy with tubular aggregates;C1861451:Stormorken syndrome;C2748557:Combined immunodeficiency due to STIM1 deficiency Uncertain:1
Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 153 of the STIM1 protein (p.Thr153Ile). This variant is present in population databases (rs144602692, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with STIM1-related conditions. ClinVar contains an entry for this variant (Variation ID: 461734). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on STIM1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.14
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.36
T;D;T;.;.;T;T;T;.
Eigen
Benign
0.020
Eigen_PC
Benign
0.21
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.89
D;D;D;D;D;D;D;T;D
M_CAP
Uncertain
0.095
D
MetaRNN
Benign
0.15
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.32
T
MutationAssessor
Benign
0.075
.;N;.;N;.;.;.;.;.
PrimateAI
Uncertain
0.53
T
PROVEAN
Uncertain
-4.0
D;D;.;D;D;D;D;D;D
REVEL
Uncertain
0.33
Sift
Benign
0.32
T;T;.;D;T;T;T;T;T
Sift4G
Benign
0.28
T;T;T;T;T;T;T;T;T
Polyphen
0.21
.;B;.;.;.;.;.;.;.
Vest4
0.39, 0.44, 0.44
MVP
0.55
MPC
1.3
ClinPred
0.066
T
GERP RS
5.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.24
gMVP
0.41

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs144602692; hg19: chr11-4076828; API